Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years

Expert Review of Clinical Immunology
Henriette Farkas, Kinga Viktória Kőhalmi

Abstract

Hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) is a rare disorder with life-threatening complications if untreated. It begins during childhood, and reduces the patient's quality of life. Therefore, the availability of an easily administered agent to relieve unpredictable HAE episodes is indispensable for this age group. Areas covered: Randomized, double-blind, placebo-controlled, open-label extensions and prospective observational studies have proven the safety and efficacy of the subcutaneously administered bradykinin B2 receptor antagonist, icatibant, in the acute treatment of HAE episodes in adult C1-INH-HAE patients. Recently, a Phase 3, multicenter, open-label, non-randomized, single-arm study demonstrated the efficacy, safety, and tolerability of icatibant as an acute treatment for pediatric patients aged 2 years to less than 18 years. Expert commentary: The clinical study in pediatric patients showed that icatibant undergoes rapid absorption, reaches a therapeutic level, and promptly relieves the symptoms. It is well tolerated, and the subcutaneous preparation, presented in a pre-filled syringe, ensures ease of use. It can be administered anytime, anywhere, and instantly - even by the patients th...Continue Reading

References

Jul 1, 1978·The Journal of Clinical Investigation·G H GoldsmithO S Ratnoff
Dec 23, 1976·The New England Journal of Medicine·J A GelfandM M Frank
Mar 1, 1991·British Journal of Pharmacology·F J HockJ Knolle
Mar 1, 1991·British Journal of Pharmacology·K WirthJ Knolle
Jul 2, 1987·The New England Journal of Medicine·D Stoppa-LyonnetT Meo
Mar 1, 1985·Peptides·R J Vavrek, J M Stewart
Apr 13, 1972·The New England Journal of Medicine·M M FrankD W Alling
Aug 31, 1972·The New England Journal of Medicine·A L ShefferF S Rosen
Jun 20, 1996·The New England Journal of Medicine·M Cicardi, A Agostoni
Sep 13, 2000·The Journal of Allergy and Clinical Immunology·K E Binkley, A Davis
May 14, 1965·Science·F S ROSENP CHARACHE
Feb 24, 2006·The American Journal of Medicine·Konrad BorkJochen Hardt
Apr 28, 2006·Biochemical and Biophysical Research Communications·Georg Dewald, Konrad Bork
Apr 10, 2007·The Journal of Allergy and Clinical Immunology·Konrad BorkWolfhart Kreuz
Dec 26, 2007·The Journal of Allergy and Clinical Immunology·Christian DrouetAlbert Adam
Jun 17, 2008·American Journal of Obstetrics and Gynecology·Laurence BouilletMarco Cicardi
Mar 7, 2009·European Journal of Dermatology : EJD·Anette BygumCarsten Sauer Mikkelsen
Jul 30, 2010·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Henriette Farkas
Jul 30, 2010·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Emel Aygören-PürsünWolfhart Kreuz
Jul 30, 2010·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Hilary J LonghurstBruce Zuraw
Jul 30, 2010·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Tom BowenZhi Yu Xiang
Sep 8, 2010·The New England Journal of Medicine·Marco CicardiWing-Tze Fan
Nov 30, 2011·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·William R LumryAvner Reshef
Dec 27, 2011·The Journal of Allergy and Clinical Immunology·Teresa CaballeroUNKNOWN C-1-INH Deficiency Working Group
Sep 28, 2012·The Journal of Allergy and Clinical Immunology·Henriette FarkasGeorge Füst
Oct 16, 2012·The Journal of Allergy and Clinical Immunology·Henriette FarkasGeorge Harmat
Feb 8, 2013·PloS One·Marcus MaurerUNKNOWN I O S Investigators
Feb 21, 2013·Allergy and Asthma Proceedings·Bruce L ZurawMarco Cicardi
Jul 24, 2013·Pediatrics·Andrew J MacGinnitieRaffi Tachdjian
Mar 29, 2014·Allergy·M CicardiUNKNOWN HAWK under the patronage of EAACI (European Academy of Allergy and Clinical Immunology)
Apr 1, 2014·Orphanet Journal of Rare Diseases·Zsuzsanna ZotterHenriette Farkas
Apr 23, 2014·Clinical and Experimental Immunology·A MalbránW Lumry
Jun 28, 2014·The Journal of Biological Chemistry·Jon A KennistonDaniel J Sexton
Jul 2, 2014·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Yung ChyungBurt Adelman
Sep 12, 2014·Pediatric Dermatology·Omar Abdel-KarimAnette Bygum
Jun 26, 2015·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Timothy J CraigAndrew J MacGinnitie
Jun 27, 2015·International Archives of Allergy and Immunology·Dolores Hernández Fernandez de RojasUNKNOWN IOS Study Group
Jul 21, 2015·The Journal of Clinical Investigation·Jenny BjörkqvistThomas Renné
Nov 12, 2015·International Archives of Allergy and Immunology·William R LumryMarc Riedl

❮ Previous
Next ❯

Citations

Jan 19, 2019·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·P Staubach
Mar 27, 2019·Expert Opinion on Biological Therapy·Francesca PeregoMarco Cicardi
Sep 25, 2019·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Sybille KempeJens Greve
Oct 9, 2019·Current Opinion in Otolaryngology & Head and Neck Surgery·C Eric Bailey, Michele M Carr
Jan 31, 2020·Clinical and Experimental Pediatrics·Young Min Ahn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.